SCHEMBL22196756

SCHEMBL22196756

CCOCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CC[S+]([O-])CC1

nearest known ligand 0.84

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 20/20 0.84
▸ FGFR3 P22607 13/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15043279 0.92 FGFR1 (1.00) FGFR1FGFR3
SCHEMBL15023888 0.89 FGFR1 (1.00) FGFR1FGFR3
SCHEMBL15020362 0.89 FGFR1 (1.00) FGFR1FGFR3
Hydrochloric Acid SCHEMBL15023170 0.89 FGFR1 (0.98) FGFR1FGFR3
SCHEMBL15043282 0.88 FGFR1 (1.00) FGFR1FGFR3
SCHEMBL15043281 0.88 FGFR1 (1.00) FGFR1FGFR3
SCHEMBL15043283 0.87 FGFR1 (1.00) FGFR1FGFR3
SCHEMBL15023388 0.87 FGFR1 (1.00) FGFR1FGFR3
SCHEMBL15043280 0.86 FGFR1 (1.00) FGFR1FGFR3
SCHEMBL15043285 0.86 FGFR1 (1.00) FGFR1FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3268490-B1 SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE-CONTAINING COMBINATIONS Bayer Pharma AG (DE) 2020-07-08 — — EP disclosed
Send feedback